🩺
Physician Portal
CROWN18 Clinical Management System
🔐
Secure Access Required
This area is restricted to licensed medical professionals. All access is logged and HIPAA-audited.
256-bit encrypted • Session timeout: 30 min • All actions recorded
C
CROWN18
CLINICAL COMMAND CENTER v2.7
142 patients • 47 online
Live • May 29, 2026
Dr. Moshe Elyasi, MD
Medical Director • Board Certified
Dr. Moshe Elyasi, MD
EM
MAY 29, 2026 • 4:08 PM EDT
Good afternoon, Dr. Moshe Elyasi, MD
Your practice is performing exceptionally well today.
+23% vs last week
Active Patients
142
👥
↑ 12 new this week
Monthly Revenue
$184,920
💵
↑ 18% from April
Pending Payments
$12,450
⏳
8 patients
Active Prescriptions
89
💊
14 refills due
Revenue Trend
Last 6 months • All services
+$41,200
Service Mix
GLP-1 Clinical Efficacy Highlights
Latest peer-reviewed data (2024–2026)
STEP • SURPASS • SURMOUNT
Semaglutide (Wegovy)
-14.9%
body weight at 68 weeks (STEP 1)
Tirzepatide (Zepbound)
-15.7% to -21%
body weight (SURPASS-2 / SURMOUNT-1)
A1C Reduction
-1.8% to -2.1%
average across trials
≥10% Weight Loss
80–87%
of patients achieved target
✓
Significant cardiovascular risk reduction • Improved glycemic control • High patient adherence in real-world studies
Live Activity Feed
REAL-TIME
AGE
CURRENT WEIGHT
GOAL WEIGHT
Weight Tracking (Last 12 Weeks)
↓ 12.4 lbs total
Weight History Table
| Week | Date | Weight (lbs) | Change |
|---|